| 1 |
Tkachev A, Stekolshchikova E, Vanyushkina A, Zhang H, Morozova A, Zozulya S, Kurochkin I, Anikanov N, Egorova A, Yushina E, Vogl T, Senner F, Schaupp SK, Reich-Erkelenz D, Papiol S, Kohshour MO, Klöhn-Saghatolislam F, Kalman JL, Heilbronner U, Heilbronner M, Gade K, Comes AL, Budde M, Anderson-Schmidt H, Adorjan K, Wiltfang J, Reininghaus EZ, Juckel G, Dannlowski U, Fallgatter A, Spitzer C, Schmauß M, von Hagen M, Zorkina Y, Reznik A, Barkhatova A, Lisov R, Mokrov N, Panov M, Zubkov D, Petrova D, Zhou C, Liu Y, Pu J, Falkai P, Kostyuk G, Klyushnik T, Schulze TG, Xie P, Schulte EC, Khaitovich P. Lipid Alteration Signature in the Blood Plasma of Individuals With Schizophrenia, Depression, and Bipolar Disorder. JAMA Psychiatry 2023;80:250-9. [PMID: 36696101 DOI: 10.1001/jamapsychiatry.2022.4350] [Reference Citation Analysis]
|
| 2 |
Liu X, Sun L, Wen W, Qiu M, Luo J, Li W, Hao S, He M, Wu J, Hu Y, Huang Y. Association between the ratio of serum eicosapentaenoic acid to arachidonic acid and risk of coronary artery disease in young Chinese patients. Front Nutr 2022;9. [DOI: 10.3389/fnut.2022.1019058] [Reference Citation Analysis]
|
| 3 |
Yang K, Cao F, Xue Y, Tao L, Zhu Y. Three Classes of Antioxidant Defense Systems and the Development of Postmenopausal Osteoporosis. Front Physiol 2022;13:840293. [DOI: 10.3389/fphys.2022.840293] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 4 |
Couttas TA, Jieu B, Rohleder C, Leweke FM. Current State of Fluid Lipid Biomarkers for Personalized Diagnostics and Therapeutics in Schizophrenia Spectrum Disorders and Related Psychoses: A Narrative Review. Front Psychiatry 2022;13:885904. [PMID: 35711577 DOI: 10.3389/fpsyt.2022.885904] [Reference Citation Analysis]
|
| 5 |
Tkachev AI, Stekolshchikova EA, Morozova AY, Anikanov NA, Zorkina YA, Alekseyeva PN, Khobta EB, Andreyuk DS, Zozulya SA, Barkhatova AN, Klyushnik TP, Reznik AM, Kostyuk GP, Khaitovich PE. Ceramides: Shared Lipid Biomarkers of Cardiovascular Disease and Schizophrenia. Consortium Psychiatricum 2021;2:35-43. [DOI: 10.17816/cp101] [Reference Citation Analysis]
|
| 6 |
Tkachev A, Stekolshchikova E, Anikanov N, Zozulya S, Barkhatova A, Klyushnik T, Petrova D. Shorter Chain Triglycerides Are Negatively Associated with Symptom Improvement in Schizophrenia. Biomolecules 2021;11:720. [PMID: 34064997 DOI: 10.3390/biom11050720] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 7 |
Wickramasekara RN, Lookian PP, Ngo J, Shibata A, Stessman HAF. Schizophrenic Psychosis Symptoms in a Background of Mild-To-Moderate Carnitine Palmitoyltransferase II Deficiency: A Case Report. Reports 2020;3:31. [DOI: 10.3390/reports3040031] [Reference Citation Analysis]
|
